PRESS RELEASE
Unicorn Capital Advisers is delighted to announce its appointment as Exclusive Adviser to Mosfarm on attracting strategic partner.
Commenting, Denis Shulyatsky, General Director, Mosfarm: “Starting from the launch date in 2005 and with the help of our professional team and employees’ commitment, Mosfarm not only successfully entered
into the Russian pharmaceutical market as a new player, but also gained partners’ and customers’ confidence and became one of leaders among infusion solutions manufacturing companies. We face with dignity challenges arising from COVID-19 crisis and are not changing our plans going forward. We laid
good foundation for further growth and learned to work in new reality. We are excited to pool our efforts on new product development with a strategic investor, supplying customers high quality, effective and competitively priced pharmaceutical products produced locally.”
Commenting, Sergei Moiseyev, Chairman, Unicorn Capital Advisers: “Today we see interest in pharmaceutical industry from strategic investors, including joint ventures. I am confident that our unique 20-year track record of advising PE funds and SME owners across a broad range of industries in Russia, will be beneficial to Mosfarm strategy accomplishment.”
###
Unicorn Capital Advisers offers leading advice on M&A and capital raising, provides management consulting to improve corporate governance.
More information is available at www.unicorncapital.com
Commenting, Denis Shulyatsky, General Director, Mosfarm: “Starting from the launch date in 2005 and with the help of our professional team and employees’ commitment, Mosfarm not only successfully entered
into the Russian pharmaceutical market as a new player, but also gained partners’ and customers’ confidence and became one of leaders among infusion solutions manufacturing companies. We face with dignity challenges arising from COVID-19 crisis and are not changing our plans going forward. We laid
good foundation for further growth and learned to work in new reality. We are excited to pool our efforts on new product development with a strategic investor, supplying customers high quality, effective and competitively priced pharmaceutical products produced locally.”
Commenting, Sergei Moiseyev, Chairman, Unicorn Capital Advisers: “Today we see interest in pharmaceutical industry from strategic investors, including joint ventures. I am confident that our unique 20-year track record of advising PE funds and SME owners across a broad range of industries in Russia, will be beneficial to Mosfarm strategy accomplishment.”
###
Unicorn Capital Advisers offers leading advice on M&A and capital raising, provides management consulting to improve corporate governance.
More information is available at www.unicorncapital.com
13 July 2020
Unicorn Capital Advisers has been awarded an investment mandate on attracting strategic partner to pharmaceutical company Mosfarm.
Unicorn Capital Advisers contacts:
Sergei Moiseyev, Chairman
Mbl. +7 967 119-90-00
sergei.moiseyev@unicorncapital.ru
Tatiana Nikitina, Director, IR and communications
Mbl. +7 967 119-92-22
tatiana.nikitina@unicorncapital.ru
Sergei Moiseyev, Chairman
Mbl. +7 967 119-90-00
sergei.moiseyev@unicorncapital.ru
Tatiana Nikitina, Director, IR and communications
Mbl. +7 967 119-92-22
tatiana.nikitina@unicorncapital.ru
Mosfarm is one of the infusion solutions manufacturers in Russia and is the only enterprise in the Moscow Region to make these medicinal products.
More information is available at www.mosfarm.su
More information is available at www.mosfarm.su